Fortis Healthcare Q1 FY27 Results Analysis: Revenue Surges 17.5%, Margins Compress Sharply

Fortis Healthcare Ltd's Q1 FY27 numbers came in mixed, with revenue of Rs. 2,545.03 Cr (+17.46% YoY) and PAT growth of +0.41% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quarter Snapshot

Fortis delivered 17.5% revenue growth, beating its 15%+ hospital revenue guidance, but margins compressed sharply missing margin guidance. Normalized PAT was nearly flat, with employee cost growth outpacing revenue. Diagnostics margin improved sequentially but remains far below the 23-24% FY27 target.

Key Investment Insights

Key Positives

• Healthcare revenue grew 19.0% YoY, exceeding the 15%+ FY27 guidance floor.
• Diagnostics revenue grew 10.2% YoY, achieving double-digit growth as guided.
• Diagnostics segment EBIT margin expanded 242 bps QoQ to 16.78%, driven by operating leverage.
• Debt/equity ratio improved to 0.31 from 0.34 in Q4 FY26, with finance costs declining 4.6% QoQ.
• Revenue from operations grew 17.5% YoY to Rs.2,545.03 Cr, the strongest Q1 growth rate.

Risk Factors

• EBITDA margin contracted 169 bps YoY to 21.67%, driven by employee cost growth of 29.3% YoY.
• Normalized PAT grew only 0.41% YoY despite 17.5% revenue growth, indicating severe operating deleverage.
• Healthcare segment EBIT margin compressed 226 bps YoY, missing the FY27 guidance of +150 bps improvement.
• Diagnostics segment EBIT margin of 16.78% is well below the FY27 guidance range of 23-24%.
• Employee benefits expense grew 29.3% YoY, nearly double revenue growth, pressured by ESOP grants and new unit hiring.